Avalon Report 2024
Avalon Report 2024
Company Profile
Company Profile
Registered SKUS in KSA
+0
Staff
+0
Export Countries
+0
Registered SKUS Globally
+0
Shareholder Information
Exchange
Saudi Stock Exchange, Tadawul – Main Market
Saudi Stock Exchange, Tadawul – Main Market
Number of Shares Issued
20,000,000
20,000,000
Market Cap at listing, as 27th February
1,640 Million SAR / 437.3 USD
1,640 Million SAR / 437.3 USD
Market Cap as of 31st December 2024
2,448 Million SAR / 652.8 USD
2,448 Million SAR / 652.8 USD
Major Shareholders — 31st December 2024
Nature of Investors
Nature
Percentage of Ownership
Ownership
Number of Investors
Investors
Number of Shares
Shares
Institutional Investors
Institutional
47.0%
47.0%
92
9,395,734
Individual Investors
Individual
53%
53%
152,067
152,067
10,604,266
10,604,266
Total
100%
100%
152,159
152,159
20,000,000
20,000,000
Investors According to Nationality
Nationality
Percentage of Ownership
Ownership
Number of Investors
Investors
Number of Shares
Shares
Saudi Arabian
96.4%
96.4%
144,734
144,734
19,288,523
19,288,523
Other Nationalities
3.6%
3.6%
7,425
7,425
711,477
711,477
Total
100%
100%
152,159
152,159
20,000,000
20,000,000
Investor Relations
Post listing, and over the course of 2024, the Company looked to engage and interact with the investor community. Through its transition period, Avalon posted strong performance figures, and moving into 2025 is looking to activate an institutionalised Investor Relations department to better serve its stakeholders.
0
Conference Attended
With 25 meetings held at the conferences
0
Investor Meetings Held (Exc Conferences)
0
Analytics Covering Avalon
Board of Directors
Ahmad Shaher Al-Tabbaa
Chairman
Ahmad Shaher Al-Tabbaa
Chairman
Hisham Attar
Vice Chairman
Hisham Attar
Vice Chairman
Faisal Al Jamaan
Board Member
Faisal Al Jamaan
Board Member
Omar Al Jaroudi
Board Member
Omar Al Jaroudi
Board Member
Mohamed Maher Al Ghannam
Board Member
Mohamed Maher Al Ghannam
Board Member
Executive Management
Mohamed Maher Al Ghannam
Managing Director & CEO
Mohamed Maher Al Ghannam
Managing Director & CEO
Mohamed Metwally
Chief Commercial Officer
Mohamed Metwally
Chief Commercial Officer
Fayez Awadeh
Chief Marketing Officer
Fayez Awadeh
Chief Marketing Officer
Moazam A. Shah
Chief Financial Officer
Moazam A. Shah
Chief Financial Officer
Rasheed Alrasheed
Chief Operations Officer
Rasheed Alrasheed
Chief Operations Officer
Hamoud Alanazi
Chief Administrative Officer
Hamoud Alanazi
Chief Administrative Officer
Mohammed Al-Moaiteq
Compliance Manger
Mohammed Al-Moaiteq
Compliance Manger
Wael Madbouly
Internal Audit Manger
Wael Madbouly
Internal Audit Manger
Avalon Pharma 2024 Report
As a proud supporter of Vision 2030, Avalon Pharma is committed to advancing healthcare through innovation and quality. We strive to deliver high-impact pharmaceutical and beauty solutions that enhance well-being, driven by sustainability, learning, and growth.
Avalon Pharma 2024 Report
As a proud supporter of Vision 2030, Avalon Pharma is committed to advancing healthcare through innovation and quality. We strive to deliver high-impact pharmaceutical and beauty solutions that enhance well-being, driven by sustainability, learning, and growth.